Brief Title
Transmuscular Quadratus Lumborum Block for Laparoscopic Cholecystectomy
Official Title
Ultrasoundguided Transmuscular Quadratus Lumborum Block After Elective Laparoscopic Cholecystectomy. A Prospective, Randomized Clinical Trial.
Brief Summary
The TQL block may prove a valuable method for treating postoperative pain following scopic removal of the gall bladder. The trial will compare active TQL block versus placebo TQL block after said operation. The hypothesis is that active TQL block significantly will reduce postoperative pain following scopic removal of the gall bladder compared with placebo TQL block.
Study Type
Interventional
Primary Outcome
Pain score in sitting position
Secondary Outcome
Pain score at rest
Condition
Cholecystitis
Intervention
Ropivacaine
Study Arms / Comparison Groups
Placebo TQL block
Description: 30 ml single shot TQL block with saline 0,9%
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Drug
Estimated Enrollment
0
Start Date
November 2014
Primary Completion Date
November 2015
Eligibility Criteria
Inclusion Criteria: - scheduled for elective laparoscopic cholecystectomy - received oral and written information about the trial - American Society of Anaethesiologists (ASA) classification 1-3 - NRS score > 3 upon arrival at the PACU area Exclusion Criteria: - Cannot cooperate - Does not speak or understand Danish - Allergy towards drugs used in the trial - Large daily consumption of opioids - Known alcohol og medicin abuse - Difficult or impossible by ultrasound to visualise the intended nerve/tissue structures necessary to perform block - Pregnancy
Gender
All
Ages
18 Years - N/A
Accepts Healthy Volunteers
No
Contacts
Jens Børglum, MD, PhD, ,
Location Countries
Denmark
Location Countries
Denmark
Administrative Informations
NCT ID
NCT02225418
Organization ID
BBH-TQL-LC
Secondary IDs
2013-001364-30
Responsible Party
Sponsor-Investigator
Study Sponsor
Jens Borglum Neimann
Collaborators
Bispebjerg Hospital
Study Sponsor
Jens Børglum, MD, PhD, Principal Investigator, Copenhagen University Hospital Bispebjerg
Verification Date
July 2015